The Industry’s Move Toward Digitally Connected Clinical Trials

The Industry’s Move Toward
Digitally Connected Trials

2
Copyright © Veeva Systems 2021
Why We Are Here Today
Explore acceleration to digital trials
Uncover how operational processes are
maturing in modern trial environments
Reveal considerations for site / patient
engagement and centricity
Discover lessons learned and implications

4
Copyright © Veeva Systems 2021. Veeva Confidential.
Digital vs. Decentralized Trials
The Distinction
HOW?
Trial Data is Collected &
Shared
WHERE?
Trials are Conducted
Digital Decentralized
Veeva’s Goal: Digitally Connected Clinical Trials, Irrespective of Operating Model

5
Veeva Digital Trials Platform
Better trials for all through a connected ecosystem
Paperless. Patient-Centric. Decentralized.
25%
Faster
25%
Less Costly
Sites
SiteVault
Patients
MyVeeva
Sponsors
Clinical Suite

6
Operationalizing Through Interoperability
Microsoft Excel
1
Connected People
Microsoft Excel
3
Connected Data
Microsoft Excel
2
Connected Process
Vertically Across Stakeholders Within a Process
Horizontally Across Stakeholders and Processes

7
Survey Method
• Global survey to clinical leaders conducted in 1H 2021
• Survey questions (9) examine rapid adoption of DCT’s and
its impact on the industry
• 15,000 participants invited
• 2185 initiated
• 289 qualified respondents
• $20 compensation for completion

8
Tech Adoption
Unprecedented Exploration
of New Technology &
Innovation
Connectivity
Clear Need for Balancing New
Ways of Working Without
Sacrificing Interoperability
Simplicity
Sponsors and CROs are
Rationalizing Systems &
Processes
Executive Summary
Challenges with Decentralized Methods are Accelerating Digital Transformation

9
Key Findings
Plan to
increase DCTs
within 24
months
95%
Say DCTs had
positive impact
on patient
experience
56% Site technology
adoption
biggest issue
70%
Decentralized methods
are here to stay
Increased site burden
Benefits not fully
realized

10
Site Engagement
De-risking site operations
and patient care
Patient
Engagement
Delivering high value
patient experience
Data /
Interoperability
Delivering visibility and
real time trial oversight
Role of Technology
Simplified stakeholder
connectivity
Future Proofing Clinical Trials #NoGoingBack

13
Site Engagement Findings
Only 29% report improved site engagement
BIGGEST CHALLENGE –
70%
Site Technology Adoption
TOP PRIORITY TO
IMPROVE – 66%
Adopting Site-Centric
Approach to Technology
“Sites burdened by too
many technologies; we
need to make it simpler for
them”
“DCTs introduce more tech,
more processes, more burden
for the site. We need to
provide a helping hand, a
white glove approach to help
them”

14
Site Engagement Implications
Veeva’s Goal: Digitize and Connect Transactional Activities so Sites Can Focus on
Patient Care and Trial Oversight
Experience
Required
Chicken and Egg?
The Great PI
Resignation?
Double the
Work
One and Done
Double the Risk?

16
Examining Patient Engagement
Only 56% report benefit to the patient experience
Burden for
technology averse
patients
50%
Data protection
and privacy
concerns
51%
Prioritizing patient
education and
training
45%
“Critically evaluate solutions that optimize the sponsor, investigator, AND the
patient experience”

17
Patient Experience Implications
Access
Serving Multiple
Masters?
A Fine Balance?
Experience Adherence
A Hot Potato?
Veeva’s Goal: Connecting a Digital Workflow Across All Trial Stakeholders Agnostic
to Patient’s Digital or Non-Digital Journey

19
CROs Leading Digital Transformation
Rapid Adoption, Cautious Deployment
Adopted Average of FOUR New Applications
Leading to Challenges with Data & System Silos
Actively Addressing Interoperability, Data
Sharing, Reducing Paper
“It is essential to evaluate relative merits of technologies but aim to use fewer
applications with better connections between them”

20
Implications to Interoperability
Scale
Can the Dust
Settle?
Forest for the
Trees?
Data Visibility
Keeping in Sync?
Veeva’s Goal: Connected Data, Stakeholders, and Workflow in a Single Platform
to Deliver Modern Trial Operations

“All of these new solutions bring additional
burden for time, cost, and quality.”
“New systems and processes have led to
inefficient internal workflows, challenges with
collaboration, and getting information in and
out of systems”
Despite progress in moving to more digital ways of working, respondents described a fragmented
technology landscape that is made even more challenging by the adoption of multiple point solutions
The State of Technology Today

23
Opportunities
Patient Experience
Technology’s Opportunity to Support the Modern Trial
Access. To trials. To trial data. To each other.
Value. Experience. Relationship. Patient care.
Connectivity. Data. People. Process.
Speed. Data processing. Visibility. Actioning.
Scale. Ways of Working. Portfolio Ready. Global.
Site Experience
Sponsor Experience

Looking Ahead
Veeva’s Commitment to Supporting Digital &
Decentralized Trials

25
Veeva’s Commitment
Anchor on
Connectivity
Sponsors, Sites,
and Patient-Centric
Insights and
Optimization Remove Paper
Single
Access
Point
Ecosystem on a
common technology
Delivering a
Connected Digital
Platform

Read the Report:
veeva.com/veeva-digital-clinical-trials-survey-report/

The Industry’s Move Toward Digitally Connected Clinical Trials

Recommended

Recommended

More Related Content

What's hot

What's hot (20)

Similar to The Industry’s Move Toward Digitally Connected Clinical Trials

Similar to The Industry’s Move Toward Digitally Connected Clinical Trials (20)

More from Veeva Systems

More from Veeva Systems (20)

Recently uploaded

Recently uploaded (20)

The Industry’s Move Toward Digitally Connected Clinical Trials